Aicaigou LogoB2B Wiki

Pharmaceutical Bottle Plastic Material

Updated: 2026-09-15

Overview

Pharmaceutical Bottle Plastic Material encompasses high-purity polymers engineered to meet stringent regulatory requirements for drug packaging. These materials must ensure product integrity by preventing leaching, moisture ingress, or chemical interactions. The most widely used resins include high-density polyethylene (HDPE), low-density polyethylene (LDPE), and polypropylene (PP), each selected for specific drug formulations and delivery methods. Global pharmacopeias such as USP, EP, and JP define testing protocols for these materials, including biological reactivity and extractables studies. Manufacturers often add stabilizers or barrier coatings to enhance performance while maintaining compliance with FDA 21 CFR or EU 10/2011 regulations for food-contact materials.

Physical and Chemical Properties

These polymers exhibit low density (0.89–0.97 g/cm³) and moderate melting points (120–170°C), making them suitable for blow molding and injection molding processes. Their non-polar nature provides excellent resistance to acids, alkalis, and most organic solvents, crucial for maintaining container integrity across pH ranges. Key metrics include oxygen transmission rate (OTR) and water vapor transmission rate (WVTR), which determine shelf-life protection. For example, PP typically shows WVTR of 0.3 g·mm/m²·day, while HDPE offers superior moisture barrier properties. Additives like clarifiers or nucleating agents may be incorporated to improve transparency or crystallization speed during production.

Main Applications

Primary use cases include solid-dose packaging (pill bottles), liquid formulations (syrup containers), and sterile applications (eye drop bottles). HDPE dominates opaque containers for moisture-sensitive drugs due to its excellent barrier properties, while PP is preferred for autoclave-compatible items like IV bottles. Specialty applications include amber-colored bottles (using PET with UV blockers) for light-sensitive medications, and multi-layer co-extruded structures incorporating EVOH barriers for oxygen-sensitive biologics. Child-resistant and senior-friendly closures often use engineered blends with precise friction coefficients for safety functionality.

Safety and Storage

Raw polymer granules must be stored in moisture-proof packaging to prevent hydrolysis degradation before processing. Facilities should maintain relative humidity below 60% and avoid cross-contamination with non-pharma grade materials during handling. Processing safety requires strict temperature control to avoid thermal degradation—exceeding 200°C during molding may generate harmful volatiles. Post-molding, containers undergo rigorous testing including USP <87> cytotoxicity and <661> physicochemical assays to verify safety. Workers should use standard PPE (dust masks, gloves) when handling raw pellets.

B2B Procurement Guide

Buyers should prioritize suppliers with ISO 15378 certification (packaging materials for medicinal products) and request full documentation including Certificate of Analysis (CoA) and Regulatory Compliance Statements. For large-volume purchases, validate the supplier's batch-to-batch consistency through third-party testing. Technical specifications should clearly define melt flow index (MFI) ranges (e.g., 0.5–2 g/10min for HDPE bottles), pigment loading limits, and any restrictions on regrind material usage. Consider regional logistics—some polymers may require climate-controlled transport to prevent moisture absorption. Negotiate pricing tiers based on annual volume commitments, with typical MOQs of 5–20 metric tons for virgin medical-grade resins.

Related Manufacturers